FDA Compliance for Peptide Therapy and BPC 157 Holt Law Peptides are surging in popularity. There's little evidence that they work. Is BPC 157 Legal? Understanding Its Status and Implications The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times